Establishment of a cholangiocarcinoma risk evaluation model based on mucin expression levels

Figure 1 Clinical significance and heterogeneity of mucins in cholangiocarcinoma. A: Survival curves generated using cohort 2 data illustrating the relationship between cholangiocarcinoma (CCA) patient survival and the mRNA levels of mucins; B: Uniform manifold approximation and projection plot visually representing the tumor cell sub-clusters within the integrated CCA dataset; C: Violin plots depicting of the relative gene expression levels of MUC1, MUC4, MUC5AC, MUC5B, MUC13, and MUC16 in CCA tumor sub-clusters.